EFFECT OF PASSIVE SMOKING ON CYP1A2 ACTIVITY IN TWINS

被引：0
|
作者：
LLEWELLYN, BE
KALOW, W
TANG, BK
PANDYA, A
SCHIEKEN, RM
MEYER, JM
NANCE, WE
机构：
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298
[2] UNIV TORONTO,TORONTO,ON,CANADA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 1995年 / 57卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：1843 / 1843
页数：1
相关论文
共 50 条
  • [21] Omeprazole weakly inhibits CYP1A2 activity in man
    Rost, KL
    Fuhr, U
    Thomsen, T
    Zaigler, M
    Brockmöller, J
    Bohnemeier, H
    Roots, I
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1999, 37 (11) : 567 - 574
  • [22] CYP1A2 ACTIVITY IN SOUTH ASIANS AND EUROPEANS.
    Perera, V.
    Gross, A. S.
    McLachlan, A. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S90 - S90
  • [23] In vivo inhibition of human CYP1A2 activity by oltipraz
    Sofowora, GG
    Choo, EF
    Mayo, G
    Shyr, Y
    Wilkinson, GR
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 47 (06) : 505 - 510
  • [24] In vivo inhibition of human CYP1A2 activity by oltipraz
    Gbemiga G. Sofowora
    Edna F. Choo
    Gail Mayo
    Yu Shyr
    Grant R. Wilkinson
    Cancer Chemotherapy and Pharmacology, 2001, 47 : 505 - 510
  • [25] Evaluation of tizanidine as a marker of canine CYP1A2 activity
    Locuson, C. W.
    Williams, P.
    Adcock, J. M.
    Daniels, J. S.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2016, 39 (02) : 122 - 130
  • [26] Pregnancy Decreases Rat CYP1A2 Activity and Expression
    Walker, Alysa A.
    Dickmann, Leslie
    Isoherranen, Nina
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (01) : 4 - 7
  • [27] Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers
    Dobrinas, Maria
    Cornuz, Jacques
    Eap, Chin B.
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (05): : 286 - 292
  • [28] CYP1A2, GSTM1, and GSTT1 Polymorphisms and Diet Effects on CYP1A2 Activity in a Crossover Feeding Trial
    Peterson, Sabrina
    Schwarz, Yvonne
    Li, Shuying S.
    Li, Lin
    King, Irena B.
    Chen, Chu
    Eaton, David L.
    Potter, John D.
    Lampe, Johanna W.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (11) : 3118 - 3125
  • [29] Pantoprazole lacks induction of CYP1A2 activity in man
    Hartmann, M
    Zech, K
    Bliesath, H
    Steinijans, VW
    Koch, H
    Wurst, W
    Mascher, H
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1999, 37 (04) : 159 - 164
  • [30] In vivo inhibition of CYP1A2 activity by oltipraz.
    Sofowora, GG
    Choo, EF
    Mayo, G
    Wilkinson, GR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 122 - 122
12345